Author Archive: Jeremy Parkinson
Stocks Eroding Under The Surface
All the indices are trading at or near their all-time highs, and with Trump tweeting daily about how fabulous the stock market is on a daily basis, we should be enthusiastic about stocks across the board, right? Wrong! Actually the breadth is poor, and more importantly, the Street appears to be booking profits at breakneck speed. […]
Most Interesting New ETFs
Video length: 00:06:50 The ETF industry continues to grow at a record pace. 178 new ETFs have launched in the US this year so far, taking the total number of US listed products to 2,041 and assets under management to about $3.3 trillion. New ETFs are getting more niche, focusing on a very narrow corner […]
Pharmacy Stocks Slammed On Signs They May Be Next To Get “Amazon’d”
Pharma stocks tumbled to their lows of the session Thursday afternoon after a double whammy of Trump declaring all out war on the opioid epidemic, but more importantly, the St. Louis Dispatch reporting that Amazon has been quietly acquiring pharmacy licenses in 12 states, suggesting Jeff Bezos is gearing up for a battle with the handful of […]
Hot Options Report For End Of Day – Thursday, Oct. 26
Top tickers for end of day: GE, BAC, SYMC, TWTR, MON, AAPL.
Alphabet Inc. 3Q17 Earnings Send Shares Higher
Alphabet Inc. (Nasdaq: GOOG) 3Q17 earnings were released after closing bell tonight, and the company posted GAAP earnings of $9.57 per share on $27.8 billion in revenue, a 20% increase (23% in constant currency) year over year. Analysts had been expecting earnings of $8.33 per share on $27.2 billion in revenue. In last year’s third quarter, the […]
Tax Reform Key To Late-Acceleration Market Phase
Given how long this recovery has run, many people assume that the US economy and stock market are in the latter stages of their bull run, ready to peak at any moment. However, Chris Senyek, Chief Investment Strategist at Wolfe Research, recently told Financial Sense Newshour that the market cycle is best characterized by six different phases […]
Analyst Makes Prescient Call Ahead Of Celgene Disappointments
Shares of Celgene (CELG) are plunging after the company slashed its 2020 sales guidance. This follows last week’s announcement that the biotech company is discontinuing a late-stage Crohn’s treatment trial. Back on October 5, and ahead of both negative events, Morgan Stanley analyst Matthew Harrison had downgraded Celgene to Underweight, citing underappreciated generic risk and […]
5 Canadian LPs Capitalizing On The Global Cannabis Opportunity
From Canada to Germany, the legal cannabis market continues to be one of the most attractive investment opportunities. The legalization trend throughout the world has created significant opportunities for companies levered to the growth of this industry and we highlighted five companies that are leading this charge. Five Cannabis Firms Leading the Global Movement […]
Microsoft Corporation FQ1 2018 Earnings Boosts Shares
Microsoft Corporation (NASDAQ:MSFT) FQ1 2018 earnings were released after closing bell tonight, and the company posted earnings of 84 cents per share, a 17% increase from last year, on $24.5 billion in sales, a 12% year-over-year increase. Wall Street had been looking for earnings of 72 cents per share on $23.5 billion in revenue. The company had […]
Market Talk- Thursday, Oct. 26
China saw a mixed close with Hang Seng’s fall balancing Shanghai’s gain. Talk for China however, focused on reports that China may offer a two tranche 5 and 10yr deals having been absent from the markets for a while. At a time when yields are so low one would expect rather larger deals than is […]
